Wall Street Zen cut shares of Aehr Test Systems (NASDAQ:AEHR – Free Report) from a sell rating to a strong sell rating in a research report sent to investors on Saturday.
A number of other research firms also recently issued reports on AEHR. Weiss Ratings upgraded shares of Aehr Test Systems from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, May 4th. Craig Hallum upgraded shares of Aehr Test Systems from a “hold” rating to a “buy” rating and set a $68.00 target price on the stock in a research report on Wednesday, April 8th. William Blair upgraded shares of Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research report on Monday, March 2nd. Finally, Lake Street Capital reiterated a “buy” rating on shares of Aehr Test Systems in a research report on Wednesday, April 8th. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $68.00.
Read Our Latest Research Report on Aehr Test Systems
Aehr Test Systems Stock Down 6.4%
Aehr Test Systems (NASDAQ:AEHR – Get Free Report) last released its earnings results on Tuesday, April 7th. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.02. Aehr Test Systems had a negative net margin of 25.23% and a negative return on equity of 7.15%. The company had revenue of $10.31 million for the quarter, compared to the consensus estimate of $10.85 million. Sell-side analysts expect that Aehr Test Systems will post -0.31 EPS for the current fiscal year.
Insider Buying and Selling at Aehr Test Systems
In other Aehr Test Systems news, VP Alistair N. Sporck sold 2,000 shares of the business’s stock in a transaction on Wednesday, April 22nd. The shares were sold at an average price of $93.50, for a total transaction of $187,000.00. Following the completion of the sale, the vice president owned 5,177 shares in the company, valued at approximately $484,049.50. The trade was a 27.87% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Alberto Salamone sold 15,000 shares of the business’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $89.57, for a total transaction of $1,343,550.00. Following the sale, the executive vice president owned 63,025 shares of the company’s stock, valued at $5,645,149.25. This trade represents a 19.22% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 375,005 shares of company stock worth $28,656,178 in the last ninety days. 6.80% of the stock is currently owned by corporate insiders.
Institutional Trading of Aehr Test Systems
A number of hedge funds and other institutional investors have recently bought and sold shares of AEHR. Royal Bank of Canada increased its stake in Aehr Test Systems by 262.7% during the 1st quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Aehr Test Systems by 8.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after acquiring an additional 1,344 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Aehr Test Systems by 7.9% in the 2nd quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock worth $201,000 after acquiring an additional 1,145 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Aehr Test Systems by 110.8% in the 2nd quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock worth $89,000 after acquiring an additional 3,617 shares in the last quarter. Finally, Rhumbline Advisers grew its stake in shares of Aehr Test Systems by 3.1% in the 2nd quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock worth $536,000 after acquiring an additional 1,254 shares in the last quarter. Institutional investors own 69.69% of the company’s stock.
About Aehr Test Systems
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Read More
- Five stocks we like better than Aehr Test Systems
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
